Pluripotent stem cells (PSCs) offer an unlimited source of human cardiovascular cells for research and the development of cardiac regeneration therapies. The development of highly efficient ...

Human pluripotent stem cells (PSCs) and their derivatives hold great potential in regenerative therapies, and recently have been used in a number of clinical trials targeting various diseases. In this ...

RICHMOND, Virginia, April 20, 2023 (GLOBE NEWSWIRE) -- FUJIFILM Wako Chemicals U.S.A., Corporation today announces the launch of a ready-to-use small molecule cocktail comprising of Chroman 1, ...

Human induced pluripotent stem cells (iPSC) derived neurons are now considered a more relevant in vitro model system for psychiatric and neurological diseases. They can be used for the development of ...

In translational stem cell culture applications, switching from research-grade to GMP-grade reagents, or vice versa, often introduces uncertainties that can disrupt clinical progress and pluripotency.

MINNEAPOLIS, Dec. 20, 2023 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) for its ...

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today ...

The progress in induced pluripotent stem cells (iPSCs) and organoid technology has addressed the lack of suitable in vitro models for human neurodevelopmental and degenerative disorders. Over the past ...

Merck to become global distributor of the European Bank of iPS Cells, excluding Japan DARMSTADT, Germany, June 15, 2017 /PRNewswire/. Merck, a leading science and technology company, today announced ...